Augmentation of T-cell response with a melanoma cell vaccine expressing specific HLA-A antigens.
Hoon
D S
DS
John Wayne Cancer Institute, Santa Monica, California 90404.
Morisaki
T
T
Uchiyama
A
A
Hayashi
Y
Y
Foshag
L J
LJ
Nizze
A J
AJ
Morton
D L
DL
D000951:Antigens, Neoplasm / Q000276:immunology; D015234:HLA-A Antigens / Q000276:immunology*; D006648:Histocompatibility; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008545:Melanoma / Q000276:immunology* / Q000628:therapy; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins / Q000276:immunology; D010865:Pilot Projects; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D000951:Antigens, Neoplasm; D015234:HLA-A Antigens; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins